News12 months ago
Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ending March 31, 2024
SAN DIEGO, May 10, 2024–(BUSINESS WIRE)–Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company focused on harnessing the power of trained...
